| Dr Melissa Marie Rickerson, MD | |
|
1502 West Meyer Road, Wentzville, MO 63385 | |
| (636) 698-6200 | |
| (636) 698-6222 |
| Full Name | Dr Melissa Marie Rickerson |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1502 West Meyer Road, Wentzville, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447488804 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 2011011368 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Marie Rickerson, MD 1502 West Meyer Road, Wentzville, MO 63385 Ph: (636) 698-6200 | Dr Melissa Marie Rickerson, MD 1502 West Meyer Road, Wentzville, MO 63385 Ph: (636) 698-6200 |
News Archive
The National Alliance of State and Territorial AIDS Directors on Thursday released the latest ADAP Watch on AIDS Drug Assistance Programs, which are federal- and state-funded programs that provide HIV/AIDS-related medications to low-income, uninsured and underinsured HIV-positive individuals.
Nearly 1 in 10 stroke patients suffer chronic and debilitating pain, typically described as sharp, stabbing or burning. It's called central poststroke pain syndrome (CPSP). It was first described more than 100 years ago, and it is treatable with medications and magnetic or electrical stimulation of the brain.
A UMass Lowell researcher who works to alleviate asthma in senior citizens has received $1 million from the U.S. Department of Housing and Urban Development to advance his work.
Numerous studies have shown a relationship between coping strategies and quality of life (QOL) among women with breast cancer. In a study published today in the online edition of Journal of Behavioral Medicine, an investigation of coping strategies and quality of life among younger women with breast cancer suggests that QOL determines the use of coping strategies.
The US Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for stroke risk reduction in patients with non-valvular atrial fibrillation (AF) marking the first approval of a new oral anticoagulant in the U.S. in more than 50 years.
› Verified 8 days ago
Miss Michele L Niemczyk, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 844-853-8937 | |
Heather Robin Joyce, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1502 West Meyer Rd, Wentzville, MO 63385 Phone: 636-698-6200 | |
Iesha Schanae Draper, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 636-332-6000 | |
Mr. Peter Krewet, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 636-332-6000 |